• 1
    Centers for Disease Control and Prevention. A Closer Look at African American Men and High Blood Pressure Control: A Review of Psychosocial Factors and Systems-Level Interventions. Atlanta: U.S. Department of Health and Human Services; 2010.
  • 2
    Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000.[see comment]. JAMA. 2003;290:199206.
  • 3
    Charles H, Good CB, Hanusa BH, et al. Racial differences in adherence to cardiac medications. J Natl Med Assoc. 2003;95:1727.
  • 4
    Douglas JG, Ferdinand KC, Bakris GL, Sowers JR. Barriers to blood pressure control in African Americans. Overcoming obstacles is challenging, but target goals can be attained. Postgrad Med. 59-62 passim, 2002 Oct 2002;112:5152.
  • 5
    Bosworth HB, Dudley T, Olsen MK, et al. Racial differences in blood pressure control: potential explanatory factors. Am J Med. 2006;119:70.e970.e15
  • 6
    Poon I, Lal LS, Ford ME, Braun UK. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study. Ann Pharmacother. 2009;43:185193.
  • 7
    Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med. 2007;120:2632.
  • 8
    Lewis LM, Askie P, Randleman S, Shelton-Dunston B. Medication adherence beliefs of community-dwelling hypertensive African Americans. J Cardiovasc Nurs. 2010;25:199206.
  • 9
    Martins D, Devang G, Teklehaimanot S, Norris K. High blood pressure knowledge in an urban African-American community. Ethn Dis. 2001;11:9096.
  • 10
    Braverman J, Dedier J. Predictors of medication adherence for African American patients diagnosed with hypertension. Ethn Dis. 2009;19:396400.
  • 11
    Kim MT, Han H-R, Hill MN, et al. Depression, substance use, adherence behaviors, and blood pressure in urban hypertensive black men. Ann Behav Med. 2003;26:2431.
  • 12
    Krousel-Wood MA, Muntner P, Joyce CJ, et al. Adverse effects of complementary and alternative medicine on antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc. 2010;58:5461.
  • 13
    Ogedegbe G, Harrison M, Robbins L, et al. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study.[see comment]. Ethn Dis. 2004;14:312.
  • 14
    Schoenthaler A, Chaplin WF, Allegrante JP, et al. Provider communication effects medication adherence in hypertensive African Americans. Patient Educ Couns. 2009;75:185191.
  • 15
    Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav. 2007;36:127137.
  • 16
    Ogedegbe G, Tobin JN, Fernandez S, et al. Counseling African Americans to control hypertension (CAATCH) trial: a multi-level intervention to improve blood pressure control in hypertensive blacks. Circ Cardiovasc Qual Outcomes. 2009;2:249256.
  • 17
    Wright JM, Mattu HS, Perry TLJ, et al. Validation of a new algorithm for BPM-100 electronic oscillometric office blood pressure monitor. Blood Press Monit. 2001;6:161165.
  • 18
    American Heart Association. Blood pressure testing and measurement. 2006; Accessed January 23, 2006.
  • 19
    Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:6774.
  • 20
    Shea S, Misera D, Ehrlich MH, et al. Correlates of nonadherence to hypertension treatment in an inner-city minority population. Am J Public Health. 1992;82:16071612.
  • 21
    Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705714.
  • 22
    Bultman DC, Svarstad BL. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns. 2000;40:173185.
  • 23
    Ogedegbe G, Mancuso CA, Allegrante JP, Charlson ME. Development and evaluation of a medication adherence self-efficacy scale in hypertensive African-American patients. J Clin Epidemiol. 2003;56:520529.
  • 24
    Lincoln NB, Nicholl CR, Flannaghan T, et al. The validity of questionnaire measures for assessing depression after stroke. Clin Rehabil. 2003;17:840846.
  • 25
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373383.
  • 26
    Hekler EB, Lambert J, Leventhal E, et al. Commonsense illness beliefs, adherence behaviors, and hypertension control among African Americans. J Behav Med 2008;31:391400.
  • 27
    Lagu T, Weiner MG, Eachus S, et al. Effect of patient comorbidities on filling of antihypertensive prescriptions. Am J Manag Care. 2009;15:2430.
  • 28
    Hill MN, Bone LR, Kim MT, et al. Barriers to hypertension care and control in young urban black men.[see comment]. Am J Hypertens. 1999;12(1O Pt 1): 951958.
  • 29
    Turner BJ, Hollenbeak C, Weiner MG, et al. Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf. 2009;18:672681.
  • 30
    Sabate E. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
  • 31
    Bogner HR, Cary MS, Bruce ML, et al. The role of medical comorbidity in outcome of major depression in primary care: the PROSPECT study. Am J Geriatr Psychiatry. 2005;13:861868.